Progyny, Inc.
PGNY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -3.15 | 0.59 | -1.71 | 1.84 |
| FCF Yield | 11.01% | 5.24% | 2.69% | 0.53% |
| EV / EBITDA | 21.27 | 53.59 | 110.64 | 130.90 |
| Quality | ||||
| ROIC | 9.92% | 9.49% | 7.51% | 25.06% |
| Gross Margin | 21.71% | 21.94% | 21.26% | 22.40% |
| Cash Conversion Ratio | 3.30 | 3.04 | 2.65 | 0.40 |
| Growth | ||||
| Revenue 3-Year CAGR | 14.04% | 29.55% | 31.65% | 29.66% |
| Free Cash Flow Growth | -6.19% | 140.00% | 222.71% | -32.01% |
| Safety | ||||
| Net Debt / EBITDA | -2.12 | -1.21 | -4.51 | -2.46 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 35.61 | 27.23 | 46.97 | 40.42 |